Stokes Family Office, LLC Viatris Inc Transaction History

Stokes Family Office, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.59 - $11.35 $12,495 - $14,789	1,303 Added 10.76%	13,409 $132,000
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $5,375 - $6,132	596 Added 5.18%	12,106 $120,000
Q1 2023 May 08, 2023	BUY	$9.2 - $12.26 $12,695 - $16,918	1,380 Added 13.62%	11,510 $110,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $88,333 - $117,102	10,130 New	10,130 $112,000
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $98,149 - $154,077	-10,005 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$12.09 - $14.68 $1,946 - $2,363	-161 Reduced 1.58%	10,005 $135,000
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $10,282 - $11,740	-776 Reduced 7.09%	10,166 $138,000
Q2 2021 Aug 12, 2021	SELL	$12.97 - $16.15 $5,330 - $6,637	-411 Reduced 3.62%	10,942 $156,000
Q1 2021 May 13, 2021	SELL	$13.59 - $18.54 $8,969 - $12,236	-660 Reduced 5.49%	11,353 $159,000
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $171,785 - $225,123	12,013 New	12,013 $225,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Stokes Family Office, LLC with notifications on news.